The clinical chronic obstructive pulmonary disease questionnaire: cut point for GOLD 2013 classification.
作者信息
Kon Samantha S C, Canavan Jane L, Nolan Claire M, Jones Sarah E, Clark Amy L, Polkey Michael I, Man William D-C
机构信息
1 NIHR Respiratory Biomedical Research Unit Royal Brompton & Harefield NHS Foundation Trust and Imperial College Harefield, United Kingdom.
出版信息
Am J Respir Crit Care Med. 2014 Jan 15;189(2):227-8. doi: 10.1164/rccm.201310-1805LE.
Abstract
摘要
相似文献
1
The clinical chronic obstructive pulmonary disease questionnaire: cut point for GOLD 2013 classification.临床慢性阻塞性肺疾病问卷：2013年慢性阻塞性肺疾病全球倡议（GOLD）分级的切点
Am J Respir Crit Care Med. 2014 Jan 15;189(2):227-8. doi: 10.1164/rccm.201310-1805LE.
2
Do GOLD stages of COPD severity really correspond to differences in health status?慢性阻塞性肺疾病（COPD）严重程度的GOLD分期真的与健康状况差异相对应吗？
Eur Respir J. 2003 Sep;22(3):444-9. doi: 10.1183/09031936.03.00101203.
3
Classification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD).根据拉丁美洲胸科学会（ALAT）分期系统和全球慢性阻塞性肺疾病倡议（GOLD）对慢性阻塞性肺疾病患者进行分类。
Arch Bronconeumol. 2017 Mar;53(3):98-106. doi: 10.1016/j.arbres.2016.08.015. Epub 2016 Dec 10.
4
Validation of the GOLD 2013 classification in predicting exacerbations and mortality in Taiwanese patients with chronic obstructive pulmonary disease.《慢性阻塞性肺疾病全球倡议（GOLD）2013版分类在预测台湾慢性阻塞性肺疾病患者急性加重和死亡率方面的验证》
J Formos Med Assoc. 2015 Dec;114(12):1258-66. doi: 10.1016/j.jfma.2014.12.003. Epub 2015 Feb 9.
5
[Chronic obstructive pulmonary disease: definition and classification of severity].[慢性阻塞性肺疾病：严重程度的定义和分类]
Ann Ist Super Sanita. 2003;39(4):461-6.
6
BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.BODE 指数和 GOLD 分期预测慢性阻塞性肺疾病患者 1 年加重风险。
Am J Med Sci. 2010 Jan;339(1):10-4. doi: 10.1097/MAJ.0b013e3181bb8111.
7
The GOLD classification has not advanced understanding of COPD.慢性阻塞性肺疾病全球倡议（GOLD）分类并未增进对慢性阻塞性肺疾病（COPD）的理解。
Am J Respir Crit Care Med. 2004 Aug 1;170(3):212-3; discussion 214. doi: 10.1164/rccm.2405010.
8
[Who's afraid of the new GOLD classification?].[谁害怕新的慢性阻塞性肺疾病全球倡议（GOLD）分级？]
Pneumologia. 2013 Jan-Mar;62(1):8-9.
9
Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.将新的慢性阻塞性肺疾病（COPD）全球倡议（GOLD）分期系统应用于美国基层医疗队列，并与医生和患者对严重程度的印象进行比较。
Int J Chron Obstruct Pulmon Dis. 2015 Jul 30;10:1477-86. doi: 10.2147/COPD.S78827. eCollection 2015.
10
The clinical utility of the GOLD classification of COPD disease severity in pulmonary rehabilitation.慢性阻塞性肺疾病（COPD）疾病严重程度的GOLD分类在肺康复中的临床应用。
Respir Med. 2008 Jan;102(1):162-71. doi: 10.1016/j.rmed.2007.07.008. Epub 2007 Sep 18.
引用本文的文献
1
A comparison of the assessment of health status between CCQ and CAT in a Chinese COPD clinical population: a cross-sectional analysis.中国慢性阻塞性肺疾病临床患者中CCQ与CAT健康状况评估的比较：一项横断面分析。
Int J Chron Obstruct Pulmon Dis. 2018 May 24;13:1675-1682. doi: 10.2147/COPD.S161225. eCollection 2018.
2
Investigating sensitivity, specificity, and area under the curve of the Clinical COPD Questionnaire, COPD Assessment Test, and Modified Medical Research Council scale according to GOLD using St George's Respiratory Questionnaire cutoff 25 (and 20) as reference.以圣乔治呼吸问卷评分25（及20）为参照，根据慢性阻塞性肺疾病全球倡议（GOLD）标准，研究临床慢性阻塞性肺疾病问卷、慢性阻塞性肺疾病评估测试及改良医学研究委员会量表的敏感性、特异性和曲线下面积。
Int J Chron Obstruct Pulmon Dis. 2016 May 18;11:1045-52. doi: 10.2147/COPD.S99793. eCollection 2016.
3
Physical Activity Characteristics across GOLD Quadrants Depend on the Questionnaire Used.根据所使用的问卷，慢性阻塞性肺疾病全球倡议（GOLD）象限的身体活动特征有所不同。
PLoS One. 2016 Mar 14;11(3):e0151255. doi: 10.1371/journal.pone.0151255. eCollection 2016.
本文引用的文献
1
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.COPDGene 研究中的 GOLD 2011 疾病严重程度分类：一项前瞻性队列研究。
Lancet Respir Med. 2013 Mar;1(1):43-50. doi: 10.1016/S2213-2600(12)70044-9. Epub 2012 Sep 3.
2
The Clinical COPD Questionnaire: response to pulmonary rehabilitation and minimal clinically important difference.临床慢性阻塞性肺疾病问卷：对肺康复的反应和最小临床重要差异。
Thorax. 2014 Sep;69(9):793-8. doi: 10.1136/thoraxjnl-2013-204119. Epub 2013 Oct 22.
3
British Thoracic Society guideline on pulmonary rehabilitation in adults.英国胸科学会关于成人肺康复的指南。
Thorax. 2013 Sep;68 Suppl 2:ii1-30. doi: 10.1136/thoraxjnl-2013-203808.
4
The five-repetition sit-to-stand test as a functional outcome measure in COPD.五连坐站测试作为 COPD 的一种功能预后指标。
Thorax. 2013 Nov;68(11):1015-20. doi: 10.1136/thoraxjnl-2013-203576. Epub 2013 Jun 19.
5
Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification.COPD 患者健康状况评分与 MRC 分级的比较：对 GOLD 2011 分类的影响。
Eur Respir J. 2013 Sep;42(3):647-54. doi: 10.1183/09031936.00125612. Epub 2012 Dec 20.
6
Reliability and validity of 4-metre gait speed in COPD.4 米步行速度在 COPD 中的可靠性和有效性。
Eur Respir J. 2013 Aug;42(2):333-40. doi: 10.1183/09031936.00162712. Epub 2012 Dec 6.
7
Outcomes for COPD pharmacological trials: from lung function to biomarkers.慢性阻塞性肺疾病（COPD）药物试验的结果：从肺功能到生物标志物
Eur Respir J. 2008 Feb;31(2):416-69. doi: 10.1183/09031936.00099306.
8
Development, validity and responsiveness of the Clinical COPD Questionnaire.慢性阻塞性肺疾病临床问卷的开发、效度及反应度
Health Qual Life Outcomes. 2003 Apr 28;1:13. doi: 10.1186/1477-7525-1-13.
9
Development of a shuttle walking test of disability in patients with chronic airways obstruction.慢性气道阻塞患者残疾程度的穿梭步行试验的开发。
Thorax. 1992 Dec;47(12):1019-24. doi: 10.1136/thx.47.12.1019.
Zotero 插件